Senator Harris comes out swinging against Alkermes and its CEO, attacking an opioid drug franchise
Alkermes has earned a high-profile political foe on Capitol Hill. And the showdown suddenly erupted into a high-stakes battle today aimed at one of the company’s franchise drugs.
California Senator Kamala Harris today came out swinging at the Waltham, MA-based company — domiciled in Ireland for tax purposes. In a letter to Alkermes $ALKS CEO Richard Pops, Harris seized on a string of reports in The New York Times and elsewhere claiming that Alkermes assigned sales reps to the courts in an attempt to beat the bushes for bigger sales of its opioid addiction drug Vivitrol.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.